Naproxen's interaction with aspirin may affect its cardioprotective effect [1]

Archives of Internal Medicine

Volumn 163, Issue 11, 2003, Pages 1374-

  Schechter, Stephen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NAPROXEN; THROMBOXANE B2;

DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EVALUATION; HEART PROTECTION; LETTER; PRIORITY JOURNAL; RISK; THROMBOCYTE AGGREGATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MYOCARDIAL INFARCTION; NAPROXEN;

EID: 0038348851     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.11.1374-a     Document Type: Letter

References (3)

1. Dalen JE. In reply [letter]. Arch Intern Med. 2002;162:2638-2639.
2. Mukherjee D, Nissen SE, Topol EJ. Lack of cardioprotective effect of naproxen [letter]. Arch Intern Med. 2002;162:2637.
3. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345:1809-1817.